|
GPSM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01890000273153E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.228140E-04 |
| Normal-vs-Stage2 |
3.040000E-02 |
| Normal-vs-Stage3 |
7.599000E-03 |
| Normal-vs-Stage4 |
2.392300E-02 |
| Stage1-vs-Stage2 |
7.368000E-01 |
| Stage1-vs-Stage3 |
2.349800E-01 |
| Stage1-vs-Stage4 |
6.197800E-01 |
| Stage2-vs-Stage3 |
5.943400E-01 |
| Stage2-vs-Stage4 |
8.249200E-01 |
| Stage3-vs-Stage4 |
8.026200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.00570000292211E-08 |
| Normal-vs-AfricanAmerican |
2.442400E-03 |
| Normal-vs-Asian |
1.103590E-01 |
| Caucasian-vs-AfricanAmerican |
3.127600E-01 |
| Caucasian-vs-Asian |
7.719000E-01 |
| AfricanAmerican-vs-Asian |
4.564600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54323000000067E-05 |
| Normal-vs-Female |
3.56849999993969E-07 |
| Male-vs-Female |
6.844200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.069700E-02 |
| Normal-vs-Extreme_Weight |
1.376170E-04 |
| Normal-vs-Obese |
5.91140000000268E-05 |
| Normal-vs-Extreme_Obese |
1.479990E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.767900E-02 |
| Normal_Weight-vs-Obese |
3.894000E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.242600E-01 |
| Extreme_Weight-vs-Obese |
6.090800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.963800E-01 |
| Obese-vs-Extreme_Obese |
4.213400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.083600E-03 |
| Normal-vs-Age(41-60Yrs) |
6.31659999972278E-07 |
| Normal-vs-Age(61-80Yrs) |
1.781589999994E-05 |
| Normal-vs-Age(81-100Yrs) |
6.863400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.490780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.793600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.858900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.959200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.005100E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.258090E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.40440000038356E-07 |
| Normal-VS-Type2 PRCC |
1.625970E-01 |
| Normal-VS-KIRP CIMP |
2.564200E-03 |
| Normal-VS-Unclassified PRCC |
1.367720E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.144700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.100160E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.552200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.63679999999333E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.221440E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.580200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.278000E-02 |
| Normal-vs-N1 |
2.586900E-04 |
| Normal-vs-N2 |
3.684100E-03 |
| N0-vs-N1 |
2.339100E-03 |
| N0-vs-N2 |
3.784000E-01 |
| N1-vs-N2 |
5.491800E-01 |
|
|
